Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice

Gastroenterology

Volumn 147, Issue 3, 2014, Pages 690-701

  Tao, Junyan ^a   Calvisi, Diego F ^b   Ranganathan, Sarangarajan ^c   Cigliano, Antonio ^b   Zhou, Lili ^c,d   Singh, Sucha ^c   Jiang, Lijie ^a   Fan, Biao ^a   Terracciano, Luigi ^e   Armeanu Ebinger, Sorin ^f   Ribback, Silvia ^b   Dombrowski, Frank ^b   Evert, Matthias ^b   Chen, Xin ^a   Monga, Satdarshan P S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d XI'AN JIAOTONG UNIVERSITY   (China)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Gene Regulation; Liver Cancer; Oncogene; Tumor Formation

Indexed keywords

BETA CATENIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR YAP1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; GENE OVEREXPRESSION; GENE SILENCING; HEPATOBLASTOMA; HEPATOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDRODYNAMICS BASED TRANSFECTION; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UNITED STATES;

GENE REGULATION; LIVER CANCER; ONCOGENE; TUMOR FORMATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BETA CATENIN; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CELL DEATH; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGIOCARCINOMA; EUROPE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; MICE; PHOSPHOPROTEINS; PROTEIN BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UNITED STATES;

EID: 84906934146     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.05.004     Document Type: Article

References (28)

1. C. Armengol, S. Cairo, and M. Fabre et al. Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model Int J Biochem Cell Biol 43 2011 265 270
2. K.N. Nejak-Bowen, and S.P. Monga Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad Semin Cancer Biol 21 2011 44 58
3. M. Imajo, K. Miyatake, and A. Iimura et al. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling EMBO J 31 2012 1109 1122
4. W.M. Konsavage Jr., S.L. Kyler, and S.A. Rennoll et al. Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells J Biol Chem 287 2012 11730 11739
5. D. Pan The hippo signaling pathway in development and cancer Dev Cell 19 2010 491 505
6. T. Mizuno, H. Murakami, and M. Fujii et al. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes Oncogene 31 2012 5117 5122
7. Y. Liu-Chittenden, B. Huang, and J.S. Shim et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP Genes Dev 26 2012 1300 1305
8. A.V. Pobbati, and W. Hong Emerging roles of TEAD transcription factors and its coactivators in cancers Cancer Biol Ther 14 2013 390 398
9. H. Bai, N. Zhang, and Y. Xu et al. Yes-associated protein regulates the hepatic response after bile duct ligation Hepatology 56 2012 1097 1107
10. M.Z. Xu, T.J. Yao, and N.P. Lee et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma Cancer 115 2009 4576 4585
11. D. Zhou, C. Conrad, and F. Xia et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene Cancer Cell 16 2009 425 438
12. H. Li, A. Wolfe, and S. Septer et al. Deregulation of Hippo kinase signalling in human hepatic malignancies Liver Int 32 2012 38 47
13. D. Lopez-Terrada, P.H. Gunaratne, and A.M. Adesina et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors Hum Pathol 40 2009 783 794
14. D.F. Tschaharganeh, X. Chen, and P. Latzko et al. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma Gastroenterology 144 2013 1530 1542
15. S. Armeanu-Ebinger, J. Wenz, and G. Seitz et al. Characterisation of the cell line HC-AFW1 derived from a pediatric hepatocellular carcinoma PLoS One 7 2012 e38223
16. A. Koch, D. Denkhaus, and S. Albrecht et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene Cancer Res 59 1999 269 273 (Pubitemid 29048850)
17. A.D. Tward, K.D. Jones, and S. Yant et al. Distinct pathways of genomic progression to benign and malignant tumors of the liver Proc Natl Acad Sci U S A 104 2007 14771 14776 (Pubitemid 350003218)
18. B. Zhao, X. Ye, and J. Yu et al. TEAD mediates YAP-dependent gene induction and growth control Genes Dev 22 2008 1962 1971 (Pubitemid 352008643)
19. B. Zhao, L. Li, and Q. Lei et al. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version Genes Dev 24 2010 862 874
20. J. Avruch, D. Zhou, and J. Fitamant et al. Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development Br J Cancer 104 2011 24 32
21. X. Huo, Q. Zhang, and A.M. Liu et al. Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma Oncol Rep 29 2013 840 846
22. J. Wang, J.S. Park, and Y. Wei et al. TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPalpha function Mol Cell 51 2013 211 225
23. R. Tsutsumi, M. Masoudi, and A. Takahashi et al. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function Dev Cell 26 2013 658 665
24. R. Turner, O. Lozoya, and Y. Wang et al. Human hepatic stem cell and maturational liver lineage biology Hepatology 53 2011 1035 1045
25. A. Cadoret, C. Ovejero, and S. Saadi-Kheddouci et al. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin Cancer Res 61 2001 3245 3249 (Pubitemid 32695006)
26. N. Harada, H. Miyoshi, and N. Murai et al. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin Cancer Res 62 2002 1971 1977 (Pubitemid 34408440)
27. N. Harada, H. Oshima, and M. Katoh et al. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations Cancer Res 64 2004 48 54 (Pubitemid 38114081)
28. K.N. Nejak-Bowen, M.D. Thompson, and S. Singh et al. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin Hepatology 51 2010 1603 1613